ライフサイエンスコーパス: contraception

1 using either nonhormonal contraception or no contraception.

2 compared with those who never used hormonal contraception.

3 ad compound targeting the male germ cell for contraception.

4 mate the effect of satisfying unmet need for contraception.

5 d be avoided by fulfilment of unmet need for contraception.

6 makes them ideal pharmaceutical targets for contraception.

7 ide attempt and suicide in users of hormonal contraception.

8 al acetate with levonorgestrel for emergency contraception.

9 nsistently associated with the use of modern contraception.

10 ight gain, and obesity, as well as emergency contraception.

11 sensitivity in the only woman using hormonal contraception.

12 nnually occur among the 90% of women who use contraception.

13 ld have profound effects on reproduction and contraception.

14 d to find ways to improve the use of regular contraception.

15 predictors of reversibility of hormonal male contraception.

16 tinib should be advised to practice adequate contraception.

17 pregnancies could be prevented by emergency contraception.

18 ns were observed for other forms of hormonal contraception.

19 a model for studies of male infertility and contraception.

20 vious year, and to report no use of hormonal contraception.

21 ocyte maturation as a potential strategy for contraception.

22 ty, and for generating novel methods of male contraception.

23 adequately protected by a regular method of contraception.

24 ted practices prior to provision of hormonal contraception.

25 or estrogen/progestin for reasons other than contraception.

26 m major organizations active in the field of contraception.

27 attempting to conceive after ceasing to use contraception.

28 ospermia and a possible drug target for male contraception.

29 2 diabetes compared with use of nonhormonal contraception.

30 rtain oral contraceptive pills for emergency contraception.

31 with women who discontinue other methods of contraception.

32 but not with decreased probability of using contraception.

33 velopments in both infertility treatment and contraception.

34 n, and 222 women used no method of long-term contraception.

35 ted with adverse changes in the provision of contraception.

36 in controlled release dosage forms used for contraception.

37 xposures: Use of different types of hormonal contraception.

38 for combination HIV prevention and hormonal contraception.

39 ce: Millions of women worldwide use hormonal contraception.

40 pplication, for example in endometriosis and contraception.

41 ations for human infertility and post-coital contraception.

42 eeding and as an important component of oral contraception.

43 who were neither pregnant nor using hormonal contraception.

44 son, and site, while accounting for time off contraception.

45 ially in those adolescents who may also need contraception.

46 any, iPLEDGE was their first introduction to contraception.

47 ovides a promising approach to hormonal male contraception.

48 who were neither pregnant nor using hormonal contraception (11 incident infections per 103 person-yea

49 n pregnant women who were not using hormonal contraception (18 incident infections per 423.5 person-y

50 CI 6.41-20.63) than women using no long-term contraception (3.71 per 100 person-years, 1.36-8.07; adj

51 who were neither pregnant nor using hormonal contraception (35 incident infections per 529.5 person-y

52 it, 443 women selected a nonhormonal form of contraception, 383 received a low-dose, estrogen-progest

53 lization (49.8; 95% CI, 11.9-209.2), or oral contraception (43.0; 95% CI, 15.5-119.3 in women).

54 n 120 million couples have an unmet need for contraception, 80 million women have unintended pregnanc

55 judged possibly related to use of emergency contraception; a case of dizziness in the ulipristal ace

56 Demographic characteristics, contraception, abortion, fetal loss, or drug use could n

57 couples in which women did not use hormonal contraception (adjusted hazard ratio 1.97, 95% CI 1.12-3

58 f HSV was significantly associated with oral contraception (adjusted odds ratio [aOR], 4.5; 95% confi

59 Whether or not the use of hormonal contraception affects risk of HIV acquisition is an impo

60 me." No women reported having used emergency contraception after unprotected sex.

61 Emergency contraception, also called the "morning-after treatment"

62 opausal hormone replacement therapy and oral contraception, also stimulates growth of regressing xeno

63 and demand satisfied with modern methods of contraception among women of reproductive age who are ma

64 ears in couples in which women used hormonal contraception and 1.51 per 100 person-years in couples i

65 100 person-years in women who used hormonal contraception and 3.78 per 100 person-years in those who

66 of potential targets for germ cell-directed contraception and a staggering number of candidate prote

67 esired fertility, women use a combination of contraception and abortion, and some societies also plac

68 line is often associated with an increase in contraception and abortion, but the causal relations are

69 ision of counselling on long-term reversible contraception and access to devices during family planni

70 by providing access to and information about contraception and by reducing socioeconomic obstacles to

71 ardize the current approach to hormonal male contraception and call for more effective means of inhib

72 e they can discuss the costs and benefits of contraception and conception with knowledgeable adults a

73 indicated that associations between hormonal contraception and depressive symptoms were stable.

74 Provision of ongoing contraception and encouragement of emergency contracepti

75 Thus, both posttransplant contraception and fertility counseling are options for f

76 velopment of therapeutic modalities for both contraception and fertility.

77 hormonally dependent diseases, hormonal male contraception and growth inhibition of extra-pituitary c

78 pulation of European descent that proscribes contraception and has large family sizes.

79 limited schooling, minimal access to modern contraception and healthcare, and gendered inequalities

80 factors for stroke in women, including oral contraception and hormone therapy, and pregnancy-associa

81 egnancies, such as availability of effective contraception and induced abortion, vary over time, then

82 od, associations between the use of hormonal contraception and mood disturbances remain inadequately

83 show alpha4 as an attractive target for male contraception and open the possibility for the potential

84 lications in women's health, such as in oral contraception and post-menopausal hormone therapy.

85 mented, facilitating studies of intrauterine contraception and reproductive tract infection.

86 s suggest null associations between hormonal contraception and risk of female-to-male HIV transmissio

87 ssociation between various forms of hormonal contraception and risk of HIV acquisition.

88 regnancies, but little is known about use of contraception and risk of unintended pregnancy in this p

89 ion at no cost and educated about reversible contraception and the benefits of LARC methods had rates

90 edroxyprogesterone acetate (DMPA) injectable contraception and the prevalence of periodontal diseases

91 Vaccines are being sought for contraception and the prevention of sexually transmitted

92 sed associations between the use of hormonal contraception and the risk of invasive breast cancer in

93 -only contraceptives, 43 used other forms of contraception, and 222 women used no method of long-term

94 f beliefs and behaviors regarding education, contraception, and animal domestication.

95 them), stillbirths averted, palliative care, contraception, and child physical and intellectual growt

96 tly more consistent use of condoms, hormonal contraception, and dual-method contraception than the co

97 cents, discuss the most effective methods of contraception, and ensure confidentiality from their par

98 ucts; used a reliable, non-barrier method of contraception, and had no visible or reported sexually t

99 nd pattern of menstruation, sexual activity, contraception, and incidence of pregnancy and gynecologi

100 to share not only in conception but also in contraception, and methods that are completely forgettab

101 his review are pain and the menstrual cycle, contraception, and preconception counseling.

102 ying patients, providing abortion for failed contraception, and prescribing birth control to adolesce

103 bout alleviating climacteric symptoms, using contraception, and preventing diseases such as osteoporo

104 e at sexual health clinics, use of emergency contraception, and sexual function).

105 s suggest that this autonomic method of male contraception appears free of major physiological and be

106 Therapeutic targets for male contraception are associated with numerous problems due

107 in, additional pregnancy, and progestin-only contraception are potential modifiable factors that incr

108 The role of hormonal contraception as a risk factor deserves further investig

109 or Disease Control categorizes every form of contraception as Category 2-benefits outweigh risks-in w

110 suicide were estimated for users of hormonal contraception as compared with those who never used horm

111 oung women who were starting a new method of contraception at a university health center or a health

112 Teenage girls and women who were provided contraception at no cost and educated about reversible c

113 ere provided with their choice of reversible contraception at no cost, and were followed for 2 to 3 y

114 al case exists for making hormonal emergency contraception available over the counter, as has happene

115 Introduction of new forms of male contraception based on both hormonal and non-hormonal pa

116 l methods for safe, reliable, and reversible contraception based on the suppression of spermatogenesi

117 itamin K antagonists (VKAs) require adequate contraception because of the potential for fetal complic

118 ion was similar for women who initiated oral contraception before 1972, when high-dose pills dominate

119 In 203 women who received emergency contraception between 72 h and 120 h after sexual interc

120 pdated information about the use of hormonal contraception, breast-cancer diagnoses, and potential co

121 Women take oral contraceptives for contraception but also for menstrual dysfunction treatme

122 of combination OCs and nonhormonal forms of contraception, but patients using progestin-only OCs dev

123 5.5-12.6 million) additional users of modern contraception by 2030 to meet the target of 75%.

124 Contraception can also improve perinatal outcomes and ch

125 Emergency contraception can prevent unintended pregnancies, but cu

126 The availability of modern contraception can reduce but never eliminate the need fo

127 contraception and encouragement of emergency contraception can reduce unintended pregnancies and the

128 cade supports a change in practice: hormonal contraception can safely be provided based on careful re

129 rging as a promising therapeutic strategy in contraception, cancer, and heart disease.

130 Data on use of hormonal contraception, clinical end points, and potential confou

131 ely, for patients using nonhormonal forms of contraception, combination OCs, and progestin-only OCs.

132 Easier access to and wider use of emergency contraception could dramatically lower the high rates of

133 se, long-lasting, injectable progestin-based contraception could mimic the high-progesterone luteal p

134 Satisfying unmet need for contraception could prevent another 104,000 maternal dea

135 To meet the unmet need for modern contraception, countries need to increase resources, imp

136 DMPA contraception does not increase vaginal mucosal CCR5(+)

137 Synthetic progesterone used in contraception drugs (progestins) can promote breast canc

138 Conclusions and Relevance: Use of hormonal contraception, especially among adolescents, was associa

139 1 acquisition and transmission with hormonal contraception, especially injectable methods, and about

140 Currently, three options for male-based contraception exist (i.e. withdrawal, condoms and vasect

141 Reproductive issues including contraception, fertility, and pregnancy are important co

142 f venous thromboembolism with newer hormonal contraception, few have examined thrombotic stroke and m

143 new agents to be used in female healthcare: contraception, fibroids, endometriosis, and certain brea

144 t cancer for every 7690 women using hormonal contraception for 1 year.

145 eders, they exhibited complete and permanent contraception for their entire reproductive lifespan, di

146 tent and correct use of effective methods of contraception for those youth who are or plan to be sexu

147 tent and correct use of effective methods of contraception for youth at risk of becoming pregnant.

148 priate, combined point estimates by hormonal contraception formulation using random-effects models.

149 dy was the inability to separate women using contraception from those who were intending to conceive.

150 gies, we recruited 501 couples discontinuing contraception from two U.S. geographic regions from 2005

151 Hormonal emergency contraception has no known medical contraindications, al

152 ng participants using long-acting reversible contraception (hazard ratio after adjustment for age, ed

153 s of a putative association between hormonal contraception (HC) and HIV acquisition have produced con

154 shows us that women currently using hormonal contraception (HC) have better scores on the Center for

155 mbined OCs have been seen as synonymous with contraception, helping to maintain ignorance of alternat

156 er December, 2011, using the terms "hormonal contraception", "HIV/acquisition", "injectables", "proge

157 elation to reproductive factors and hormonal contraception in a prospective cohort study of US Black

158 n of infection in pregnant women and funding contraception in epidemic regions.

159 r than 50% of women in need of FP use modern contraception in Senegal.

160 If hormonal contraception in the human functions the same way, the a

161 Tubal sterilization is a common form of contraception in the United States and is hypothesized t

162 ion between vasectomy, a common form of male contraception in the United States, and prostate cancer

163 es are the most popular reversible method of contraception in the United States.

164 lization is an increasingly common method of contraception in the United States.

165 women using low-efficacy contraception or no contraception, in models adjusted for propensity scores

166 id pregnancy and therefore needing effective contraception increased substantially, from 716 million

167 Among 16-24 year olds, non-use of contraception increased with declining age at first inte

168 ogical research into whether use of hormonal contraception increases women's risk of HIV acquisition

169 he rate of failure of long-acting reversible contraception (intrauterine devices [IUDs] and implants)

170 , years of prostitution, workplace, hormonal contraception, intrauterine-device use, alcohol consumpt

171 of LH and FSH permits a feasible approach to contraception involving selective blockade of gonadotrop

172 We provide evidence that use of contraception is a substantial and effective primary pre

173 the "morning-after treatment" or postcoital contraception is a way to prevent pregnancy after unprot

174 is known about whether contemporary hormonal contraception is associated with an increased risk of br

175 Male hormonal contraception is efficacious, reversible and well tolera

176 Effective contraception is essential in women with prior gestation

177 Male hormonal contraception is highly effective, with perfect use fail

178 However, if hormonal emergency contraception is inadvertently taken in early pregnancy,

179 Ensuring that the need for contraception is met and that all abortions are safe wil

180 : To investigate whether the use of hormonal contraception is positively associated with subsequent u

181 y virus (HIV) transmission risk and hormonal contraception is sparse and conflicting.

182 inally, the mechanism of action of emergency contraception is still unknown, although studies continu

183 The effectiveness of long-acting reversible contraception is superior to that of contraceptive pills

184 Emergency contraception is used to prevent pregnancy after a coita

185 childbearing, yet reasons for varying use of contraception itself remain insufficiently understood.

186 nd recommendations on long-acting reversible contraception (LARC) in the teen population, in order to

187 Long-acting reversible contraception (LARC), specifically intrauterine devices

188 adjusted for left truncation or time off of contraception (</= 2 months) before enrollment.

189 o indicate that hormonal strategies for male contraception may interfere with the blood-testis barrie

190 Hormonal contraception may reduce levels of depressive symptoms a

191 The widespread use of hormonal contraception may substantially increase the human S. au

192 Short-acting contraception methods (eg, oral contraceptives) can be u

193 uch as the subdermal implant or intrauterine contraception; most counseling focused on oral contracep

194 The decision to use hormonal contraception must be individualized, but the small abso

195 contraceptive pills (n = 32), or no hormonal contraception (n = 33).

196 emale users of LARC and moderately effective contraception (n = 619).

197 who were not pregnant and not using hormonal contraception (n=178), serum vitamin A was highly predic

198 We now report contraception of male nonhuman primates (Macaca radiata)

199 Participants were provided with reversible contraception of their choice at no cost.

200 ted the effect of initiating use of hormonal contraception on cervical HSV detection.

201 Valley to assess the impact of dose of oral contraception on risk of ovarian cancer.

202 linical evidence of an influence of hormonal contraception on some women's mood, associations between

203 The impact of hormonal contraception on time to HIV transmission from HIV-posit

204 d most commonly used for injectable hormonal contraception, on HSV type 1 (HSV-1) reactivation and CD

205 is occurs in subjects receiving estrogen for contraception or hormone replacement, or in susceptible

206 ause), exogenous sex hormones (e.g. hormonal contraception or hormone therapy) also may modulate migr

207 l: 0.14, 0.95) than women using low-efficacy contraception or no contraception, in models adjusted fo

208 tive women who were using either nonhormonal contraception or no contraception.

209 Given the wide use of oestrogen (contraception, osteoporosis and menopause), more researc

210 tivariable analysis controlling for hormonal contraception, other STIs, behavioral, and demographic f

211 men (12.5%) after initiating use of hormonal contraception (P=.4).

212 itive evidence about the effects of hormonal contraception, particularly DMPA, on HIV risk.

213 ed by our sample is attributable to hormonal contraception (population-attributable fraction).

214 cy), or a reproductive factor in women (oral contraception, postmenopausal hormone therapy, or pregna

215 ms included bariatric procedures, fertility, contraception, pregnancy, and nutritional deficiencies.

216 emale exposure to reproductive factors (oral contraception, pregnancy/puerperium, and postmenopausal

217 Only 35% had contraception prescribed within 12 months of becoming pr

218 ontrast to early medical abortion, emergency contraception prevents a pregnancy from starting and doe

219 Women discontinuing contraception provided daily first-morning urine specime

220 a-uterine systems for long-acting reversible contraception provides strong impetus to define immunomo

221 Additionally, new approaches to contraception remain elusive.

222 n-surgical methods of long-term or permanent contraception remains a challenge.

223 A pharmacologic approach to male contraception remains a longstanding challenge in medici

224 To examine associations between method of contraception, sexually transmitted diseases (STDs), and

225 After cessation of male hormonal contraception, sperm output fully recovers in a predicta

226 Upon stopping contraception, subjects provided daily urine specimens a

227 Upon stopping contraception, subjects provided daily urine specimens a

228 ly updated information about use of hormonal contraception, suicide attempt, suicide, and potential c

229 oms, hormonal contraception, and dual-method contraception than the control group.

230 with an effective alternative for emergency contraception that can be used up to 5 days after unprot

231 vide highly effective, reversible, long-term contraception that is appropriate for many women after f

232 ive after 1 year despite intercourse without contraception) that was first diagnosed at the Mayo Clin

233 pared with women who had never used hormonal contraception, the relative risk of breast cancer among

234 After discontinuation of hormonal contraception, the risk of breast cancer was still highe

235 was changed to those who never used hormonal contraception, the RR estimates for users of combined or

236 A cohort of 501 couples who discontinued contraception to become pregnant was prospectively follo

237 , and what proportion of women use emergency contraception to try to prevent pregnancy.

238 history of ovarian cancer, duration of oral contraception use, tubal ligation, gravidity, education,

239 sexually transmitted disease (STD) symptoms, contraception use, unplanned pregnancies, and sociodemog

240 The success rate of male hormonal contraception using injectable testosterone alone is hig

241 this approach, which we refer to as vectored contraception (VC).

242 in cervical HSV after initiation of hormonal contraception was -313 copies/swab.

243 ong all current and recent users of hormonal contraception was 1.20 (95% confidence interval [CI], 1.

244 Use of emergency contraception was most commonly reported among black Car

245 Use of hormonal contraception was positively associated with subsequent

246 Emergency contraception was used by 113 (11.8%) of women who reque

247 , the proportions reporting use of emergency contraception were higher in young women than in older w

248 nutrition, fertility, cesarean delivery, and contraception were limited.

249 farction associated with the use of hormonal contraception were low, the risk was increased by a fact

250 Usual costs for contraception were maintained at all sites.

251 ditional pregnancy and use of progestin-only contraception were marginally associated with diabetes r

252 in maternal mortality if the unmet need for contraception were met, at country, regional, and world

253 icrobiome compositional subtype and hormonal contraception were significantly associated with genital

254 l first-in-class nonsteroidal PR agonist for contraception with improved safety and side effect profi

255 s treatment with MIS may provide a method of contraception with the unique characteristic of blocking

256 Participants were educated about reversible contraception, with an emphasis on the benefits of LARC

257 family planning clinic requesting emergency contraception within 5 days of unprotected sexual interc

258 le population, 1696 women received emergency contraception within 72 h of sexual intercourse (ulipris

259 egnancy rate in women who received emergency contraception within 72 h of unprotected sexual intercou

260 h package, meeting 90% of the unmet need for contraception would reduce global births by almost 28 mi